The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

microport.com

Founded Year

2016

Stage

PIPE - II | IPO

Market Cap

36.30B

About MicroPort Scientific Corporation

MicroPort Scientific Corporation (00853.HK) is a medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 15 seconds in thousands of major hospitals around the world, the MicroPort Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiology, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others.

MicroPort Scientific Corporation Headquarter Location

1601 Zhangdong Road Z.J. Hi-Tech Park

Shanghai, Shanghai, 201203,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing MicroPort Scientific Corporation

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

MicroPort Scientific Corporation is included in 1 Expert Collection, including Diabetes.

D

Diabetes

1,750 items

Latest MicroPort Scientific Corporation News

Global Interventional Neurology Market to Surpass US$ 3,702.6 Million by 2030, Says Coherent Market Insights (CMI)

Jun 24, 2022

Pune, INDIA Seattle, June 24, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global interventional neurology market is estimated to be valued at US$ 2,450.6 million in 2022 and is expected to exhibit a CAGR of 5.3% during the forecast period (2022-2030). Key Trends and Analysis of the Global Interventional Neurology Market: Major players operating in market are focusing on adopting strategies such as receiving product approvals, which is expected to drive the market growth over the forecast period. For instance, in April 2022, Boston Scientific Corporation, providing innovative medical solutions, received the U.S. Food and Drug Administration (FDA) 510(k) clearance for the EMBOLD Fibered Detachable Coil, which is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. The EMBOLD Fibered Coil was designed for use in a variety of embolization procedures, a minimally invasive treatment intended to block one or more blood vessels to obstruct or reduce blood flow. Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/56 Key Market Takeaways: Global interventional neurology market is expected to exhibit a CAGR of 5.3% during the forecast period due to the increasing adoption of inorganic strategies such as collaborations and agreements by the key players in market. For instance, in February 2022, Cardiovascular Systems (CSI), a medical device company, and Innova Vascular, engaged in developing innovative medical devices for treating vascular disease using minimally invasive approach, signed a collaboration agreement for the development of a full line of new thrombectomy devices. Thrombectomy is an interventional procedure performed to remove blood clots from veins and arteries. Among product types, the embolic coils segment is expected to dominate the segment growth over the forecast period, owing to increased product launches by key players operating in market. For instance, in January 2018, Cerenovus, part of Johnson & Johnson Medical Devices Companies and a global leader in neurovascular care, launched next generation embolic coil for treatment of cerebral aneurysms and stroke. On the basis of application, the Cerebral Aneurysm segment is expected to dominate the segment growth over the forecast period, owing to its increasing prevalence. For instance, according to the Brain Aneurysm Foundation, a globally recognized leader in brain aneurysm awareness, education, support, advocacy, and research funding, an estimated 6.5 million people in the U.S. have an unruptured brain aneurysm every year Competitive Landscape: Key players operating in the global interventional neurology market include Penumbra, Inc., Medtronic, Stryker, Terumo Corporation, Johnson & Johnson Services, Inc., Boston Scientific Corporation, MicroPort Scientific Corporation, Merit Medical Systems, W. L. Gore & Associates, Inc., Abbott, Cook, and Palex Medical. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/56 Market Segmentation: Embolic Coils Cerebral Aneurysm Angioplasty Hospitals North America

MicroPort Scientific Corporation Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

MicroPort Scientific Corporation Rank

  • When was MicroPort Scientific Corporation founded?

    MicroPort Scientific Corporation was founded in 2016.

  • Where is MicroPort Scientific Corporation's headquarters?

    MicroPort Scientific Corporation's headquarters is located at 1601 Zhangdong Road, Shanghai.

  • What is MicroPort Scientific Corporation's latest funding round?

    MicroPort Scientific Corporation's latest funding round is PIPE - II.

  • Who are the investors of MicroPort Scientific Corporation?

    Investors of MicroPort Scientific Corporation include Hillhouse Capital Management, E Fund, Country Garden Venture Capital, Wicrenet, L Squared Capital Partners and 13 more.

  • Who are MicroPort Scientific Corporation's competitors?

    Competitors of MicroPort Scientific Corporation include Ceryx Medical.

You May Also Like

Impulse Dynamics Logo
Impulse Dynamics

Impulse Dynamics is a medical device company dedicated to transforming the treatment of chronic heart failure. With global headquarters in Mount Laurel, N.J., the company has additional offices in Stuttgart, Germany; Orangeburg, N.Y.; and Willemstad, Curacao. Impulse Dynamics was founded in 1998 and is based in Mount Laurel, New Jersey.

A
Abbott

Abbott develops medical devices and solutions for cardiovascular conditions. It is based in Abbott Park, Illinois.

Ceryx Medical Logo
Ceryx Medical

Ceryx Medical develops a bioelectronic technology that could change the way diseases such as heart failure are treated. Employing biomimetic design principles and patented electronics, Ceryx has created a range of smart bioelectronic medical devices that speak the same language as the human body. The company was founded in 2016 and is based in Cardiff, Wales.

Medtronic Logo
Medtronic

Medtronic (NYSE:MDT) is a healthcare solutions company committed to improving lives through medical technologies, services, and solutions. The company was founded in 1949 and is based in Minneapolis, Minnesota.

Boston Scientific Logo
Boston Scientific

Boston Scientific (NYSE: BSX) is a worldwide developer, manufacturer and marketer of medical devices. The company's products are used in a broad range of interventional medical specialties. The Neuromodulation Group provides the development of implantable, high-technology neurostimulation devices that include treatments for deafness and chronic pain.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.